细胞生物学
再生(生物学)
突变体
NAD+激酶
克拉斯
功能(生物学)
生物
肺
腺癌
癌症研究
突变
遗传学
癌症
内科学
医学
生物化学
基因
酶
作者
Dane Sessions,Kee‐Beom Kim,Jennifer A. Kashatus,Nikolas Churchill,Kwon-Sik Park,Marty W. Mayo,Hiromi Sesaki,David F. Kashatus
出处
期刊:Cell Reports
[Elsevier]
日期:2022-12-01
卷期号:41 (11): 111818-111818
被引量:22
标识
DOI:10.1016/j.celrep.2022.111818
摘要
Oncogenic KRas activates mitochondrial fission through Erk-mediated phosphorylation of the mitochondrial fission GTPase Drp1. Drp1 deletion inhibits tumorigenesis of KRas-driven pancreatic cancer, but the role of mitochondrial dynamics in other Ras-driven malignancies is poorly defined. Here we show that in vitro and in vivo growth of KRas-driven lung adenocarcinoma is unaffected by deletion of Drp1 but is inhibited by deletion of Opa1, the GTPase that regulates inner membrane fusion and proper cristae morphology. Mechanistically, Opa1 knockout disrupts cristae morphology and inhibits electron transport chain (ETC) assembly and activity, which inhibits tumor cell proliferation through loss of NAD+ regeneration. Simultaneous inactivation of Drp1 and Opa1 restores cristae morphology, ETC activity, and cell proliferation indicating that mitochondrial fission activity drives ETC dysfunction induced by Opa1 knockout. Our results support a model in which mitochondrial fission events disrupt cristae structure, and tumor cells with hyperactive fission activity require Opa1 activity to maintain ETC function.
科研通智能强力驱动
Strongly Powered by AbleSci AI